Role of VEGFR‐1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib

The vascular endothelial growth factor receptor‐1 (VEGFR‐1) is a tyrosine kinase receptor frequently expressed in melanoma. Its activation by VEGF‐A or placental growth factor (PlGF) promotes tumour cell survival, migration and invasiveness. Moreover, VEGFR‐1 stimulation contributes to pathological...

Descripción completa

Detalles Bibliográficos
Autores principales: Atzori, Maria Grazia, Ceci, Claudia, Ruffini, Federica, Trapani, Mauro, Barbaccia, Maria Luisa, Tentori, Lucio, D'Atri, Stefania, Lacal, Pedro Miguel, Graziani, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933379/
https://www.ncbi.nlm.nih.gov/pubmed/31758648
http://dx.doi.org/10.1111/jcmm.14755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933379/
https://www.ncbi.nlm.nih.gov/pubmed/31758648
http://dx.doi.org/10.1111/jcmm.14755

Ejemplares similares